Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07JYF
|
|||
Former ID |
DNC005121
|
|||
Drug Name |
6-Nitro-benzothiazole-2-sulfonic acid amide
|
|||
Synonyms |
CHEMBL186335; 6-nitro-2-benzothiazolesulfonamide; 6-Nitro-benzothiazole-2-sulfonic acid amide; SCHEMBL10347981; VDPWQQORTOWPSP-UHFFFAOYSA-N; 6-nitrobenzothiazole-2-sulfonamide; BDBM50155503
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C7H5N3O4S2
|
|||
Canonical SMILES |
C1=CC2=C(C=C1[N+](=O)[O-])SC(=N2)S(=O)(=O)N
|
|||
InChI |
1S/C7H5N3O4S2/c8-16(13,14)7-9-5-2-1-4(10(11)12)3-6(5)15-7/h1-3H,(H2,8,13,14)
|
|||
InChIKey |
VDPWQQORTOWPSP-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Carbonic anhydrase II (CA-II) | Target Info | Inhibitor | [1] |
KEGG Pathway | Nitrogen metabolism | |||
Proximal tubule bicarbonate reclamation | ||||
Collecting duct acid secretion | ||||
Gastric acid secretion | ||||
Pancreatic secretion | ||||
Bile secretion | ||||
NetPath Pathway | IL4 Signaling Pathway | |||
EGFR1 Signaling Pathway | ||||
Reactome | Erythrocytes take up carbon dioxide and release oxygen | |||
Erythrocytes take up oxygen and release carbon dioxide | ||||
Reversible hydration of carbon dioxide | ||||
WikiPathways | Reversible Hydration of Carbon Dioxide | |||
Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes | ||||
Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes |
References | Top | |||
---|---|---|---|---|
REF 1 | Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives. Bioorg Med Chem Lett. 2004 Nov 15;14(22):5703-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.